Cancer Vaccines & Oncolytic Therapies

Cancer vaccines and oncolytic therapies represent rapidly developing approaches designed to stimulate or enhance antitumor immune responses. This session examines preventive and therapeutic vaccine platforms, tumor-specific antigens, personalized vaccination strategies, viral therapies, combination approaches, and clinical translation.

Abstract Scope and Participation

Submissions may cover neoantigen vaccines, RNA and DNA vaccines, peptide and protein vaccines, dendritic-cell vaccines, oncolytic viruses, vaccine delivery, immune monitoring, combination immunotherapy, and clinical development. Researchers, immunologists, oncologists, virologists, and biotechnology professionals are welcome.